Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Safety and Pharmacokinetic Study of CVM-1118 Extended-Release Capsules Administered Orally to Patients With Advanced Cancers

NCT04336124 is registered in ClinicalTrials.gov with TaiRx, Inc. as lead sponsor.

NCT NCT04336124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04336124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Safety and Pharmacokinetic Study of CVM-1118 Extended-Release Capsules Administered Orally to Patients With Advanced Cancers
Lead sponsor
TaiRx, Inc.
Phase
Phase 1
Overall status
Completed
Start date
May 25, 2020
Completion date
April 8, 2022
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer